NRG-BN010: A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
Publication Date
11-17-2022
Presented At:
SNO Annual Meeting
Content Type
Presentation
Citation
Kotecha, Rupesh and Mehta, Minesh, "NRG-BN010: A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma" (2022). All Publications. 4683.
https://scholarlycommons.baptisthealth.net/se-all-publications/4683